Otrivin Complex nasal spray 0.6 mg / ml + 0.5mg / ml bottle 10ml # 1

Dosage form

clear colorless or slightly colored odorless solution

Structure

Ipratropium bromide - 0.6 mg, xylometazoline g / c - 0.5 mg

Excipients: glycerol, disodium edetate dihydrate, concentrated hydrochloric acid.

sodium hydroxide, water up to 1 ml

pharmachologic effect

Conquer 4 cold symptoms at once: congestion, swelling, nasal flow, sneezing

Selling features

Available without a prescription

Indications

ARI, accompanied by congestion, acute allergic rhinitis, sinusitis, hay fever, edema and hyperemia of the nasal cavity.

Contraindications

Hypersensitivity to components, glaucoma, pregnancy, breastfeeding period, children under 18, brain surgery.

Dosage

Adults 1 injection into each nasal passage 3 times a day for no more than 7 days.

Name ENG

OTRIVIN COMPLEX

Clinical and pharmacological group

A vasoconstrictor drug for local use in ENT practice

ATX code

Xylometazoline in combination with other drugs

Dosage

0.6mg / ml + 0.5mg / ml x 10ml

Structure

Ipratropium bromide - 0.6 mg, xylometazoline g / c - 0.5 mg

Excipients: glycerol, disodium edetate dihydrate, concentrated hydrochloric acid.

sodium hydroxide, water up to 1 ml

Indications

ARI, accompanied by congestion, acute allergic rhinitis, sinusitis, hay fever, edema and hyperemia of the nasal cavity.

Contraindications

Hypersensitivity to components, glaucoma, pregnancy, breastfeeding period, children under 18, brain surgery.

Storage conditions and periods

At a temperature not higher than 25 degrees.

Expiration date: 3 years

INN / Active ingredient

Xylometazoline + Ipratropium bromide

Specifications

Category

Runny nose

Scope of the medicinal product

Ear, Throat, Nose

Release form

Spray

Manufacturer country

Switzerland

Package quantity, pcs

one

Scope of application

Virology

Minimum age from

18 years

Way of introduction

Intranasally

Vacation conditions

Without recipe

Volume, ml.

10 ml

Brand name

Otrivin

The amount of the dosage form in the primary package

10 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Decongestant

Anatomical and therapeutic characteristics

R01AB06 Xylometazoline, in combination with other drugs

Dosage form

Nasal spray

Expiration date in days

1095

Package weight, g

ten

Mode of application

:

Adults 1 injection into each nasal passage 3 times a day for no more than 7 days.

Dosage (volume) of the substance in the preparation

:

ipratropium bromide monohydrate 0.6 mg, xylometazoline hydrochloride 0.5 mg